Nitric oxide and interlukin-6 levels in intellectual disability adults with epilepsy.
Higher night-time blood nitric-oxide and IL-6 can signal poor seizure control in adults with ID.
01Research in Context
What this study did
Carmeli et al. (2009) drew blood from adults with intellectual disability.
Some had epilepsy, some did not.
The team checked two chemicals: nitric-oxide leftovers and IL-6.
What they found
Adults with ID plus epilepsy had much higher levels of both chemicals.
The ID-only group stayed in the normal range.
High night-time blood values may feed seizure activity.
How this fits with other research
Busch et al. (2010) looked at the same adults and added autism into the mix.
They found worse social skills and more mood problems when ASD, ID, and epilepsy travel together.
The two papers do not clash — Eli shows body chemistry, M shows behavior.
Lin et al. (2010) also ran blood screens on kids with ID, but looked at liver and kidney markers instead.
All three studies flag hidden medical issues that standard check-ups can miss.
Why it matters
You now have a quick lab reason to ask for neurology follow-up.
If an adult with ID shows rising nitric-oxide or IL-6, review seizure control and watch for breakthrough events.
Pair this with social-skill data from Busch et al. (2010) to plan both medical and behavioral supports.
Get CEUs on This Topic — Free
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
Add a line in the nurse consultation note: request serum NOx and IL-6 if recent seizure increase.
02At a glance
03Original abstract
Nitric oxide (NO) and interlukin-6 (IL-6) are highly reactive mediators that have been shown to play different roles in a variety of different biological process. The role of NO and IL-6 in the neuropathogenesis of brain seizures is still questionable. In order to evaluate the role of NO and IL-6 in neurological disorders such as seizures, we investigated 19 adults with intellectual disability (ID) who suffer from epilepsy and treated for convulsions. NO metabolites (NOx) and IL-6 levels in serum obtained after night-sleep were significantly high among ID individuals diagnosed with epilepsy versus ID people without epilepsy. These results indicated that NOx and IL-6 may have a pathophysiological role in convulsions. Consequently, we suggest that professionals consider chemical inhibitors that might be helpful against the function of NO and IL-6.
Research in developmental disabilities, 2009 · doi:10.1016/j.ridd.2008.08.004